Early Success After Thymectomy Predicts Long-term Benefits for MG Patients, Study Finds
Achieving minimal disease symptoms six months after thymectomy predicts favorable long-term outcomes in people with myasthenia gravis (MG), a study suggests.
Articles by Marisa Wexler, MS
Rituximab Safe and Effective in LOMG, Study Suggests
Treatment with rituximab is safe, provides clinical improvements and enables stopping maintenance therapies in patients with late-onset myasthenia gravis…
Guidelines Published for Managing MG During COVID-19 Outbreak
New guidelines have been published to help patients and physicians manage myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome…
Increasing Expenses for MG Patients In China Suggest Inadequacy of Current Medical Insurance Policies, Study Says
Out-of-pocket expenses for people in China who have myasthenia gravis increased from 2013 to 2015, suggesting that current policies for…
Anti-inflammatory Molecule Safely and Quickly Treats Generalized MG, Phase 2 Trial Reports
An anti-inflammatory molecule, known as the complement inhibitor zilucoplan, was seen to significantly ease disease severity in generalized myasthenia…
Case Report Highlights Very Late-onset MG in Woman, 93
Myasthenia gravis (MG) can occur in very elderly patients, a recent case report highlights. As such, there is a need…
MG Treatments Should Consider Patients’ Elevated Risk Of Serious Infections, Study Suggests
People with myasthenia gravis (MG) are at higher risk of developing serious infections than those without the condition, a recent…
Anticholinergic Drugs Could Be Safely Used for ‘Death Rattle’ Breathing in MG, Case Report Suggests
The anticholinergic agent glycopyrrolate — known to decrease stomach acid and saliva production — could be safely used to…
Probiotics May Have Therapeutic Effect on Myasthenia Gravis Symptoms, Rat Study Suggests
Administration of the probiotic bifidobacteria may ease myasthenia gravis (MG) symptoms by regulating the behavior of immune cells…
Variations in Immune System Gene Linked to Late-onset MG Risk, Meta-analysis Suggests
Variations in the gene DRB1 are associated with different risks of developing late-onset myasthenia gravis (LOMG), a recent…